To clarify the spatial localization of dopamine (DA) and norepinephrine (NE) in the basal hypothalamus of the rat, superficial, intermediate or deep portions of the basal hypothalamus were assayed for these amines. Superficial basal hypothalamic specimens (av. wt. 0.45 mg) comprising mainly the median eminence (ME) had the highest concentrations of DA (>10 µ g/g tissue). The intermediate and deep specimens, which included increasing amounts of tissue adjacent to and deep to the ME, had lower concentrations (5 and 3 µ g/g, respectively). In contrast, the concentrations of NE did not differ in the three preparations and averaged 2 µ g/g. The concentration of epinephrine, a substance which can interfere with the assay for NE, was less than 0.1 µ g/g. These results indicate that DA in the basal hypothalamus is concentrated in the ME, and confirm previously published histochemical and pharmacological studies indicating that DA is the predominant catecholamine in this region.

Keywords:
Dopamine (DA), Epinephrine, Norepinephrine (NE), Median eminence
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.